指南与共识真菌感染细菌感染、耐药与抗菌药物

抗真菌药物管理中的问题:不应错失的机会

Issues in antifungal stewardship: an opportunity that should not be lost.
指南 / 共识 · J Antimicrob Chemother · 2017-01-01

过去二十年许多国家侵袭性真菌感染(IFI)发病率上升,新危险因素和新病原体出现。因临床表现不特异和快速诊断受限,超过半数病例抗真菌治疗不当,耐药渐增。2015年印度微生物学家协会德里分会与BSAC在新德里举办一日研讨会,制定抗真菌药物管理路线图。

要点

  • IFI发病率上升且新病原体出现,早期诊断和恰当治疗是成功关键。
  • 超过半数病例抗真菌治疗不当,与临床表现不特异和快速诊断受限有关。
  • 酵母菌和丝状真菌抗真菌耐药日益常见,需建立抗真菌药物管理规划。

核心结论

  • 需要制定抗真菌药物管理路线图以优化IFI患者结局、减少抗真菌药物不合理使用及其后果。

主要发现

  • 许多国家过去二十年IFI发病率上升,出现新危险因素和新真菌病原体。
  • 因临床表现不特异和快速诊断可及性有限,超过半数病例抗真菌治疗不当。
  • 酵母菌和丝状真菌中抗真菌耐药越来越常见。

关键数值与推荐

  • 研讨会讨论IFI管理中的流行病学、不同医疗环境下的诊断和治疗算法等问题。
  • deliberations 后形成共识意见和关键信息,概述分步应对IFI和耐药增长的方法。

临床怎么用

  • 在IFI管理中应重视早期诊断和恰当抗真菌治疗,并推动建立抗真菌药物管理规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many countries have observed an increase in the incidence of invasive fungal infections (IFIs) over the past two decades with emergence of new risk factors and isolation of new fungal pathogens. Early diagnosis and appropriate antifungal treatment remain the cornerstones of successful outcomes. However, due to non-specific clinical presentations and limited availability of rapid diagnostic tests, in more than half of cases antifungal treatment is inappropriate. As a result, the emergence of antifungal resistance both in yeasts and mycelial fungi is becoming increasingly common. The Delhi Chapter of the Indian Association of Medical Microbiologists (IAMM-DC) organized a 1 day workshop in collaboration with BSAC on 10 December 2015 in New Delhi to design a road map towards the development of a robust antifungal stewardship programme in the context of conditions in India. The workshop aimed at developing a road map for optimizing better outcomes in patients with IFIs while minimizing unintended consequences of antifungal use, ultimately leading to reduced healthcare costs and prevention development of resistance to antifungals. The workshop was a conclave of all stakeholders, eminent experts from India and the UK, including clinical microbiologists, critical care specialists and infectious disease physicians. Various issues in managing IFIs were discussed, including epidemiology, diagnostic and therapeutic algorithms in different healthcare settings. At the end of the deliberations, a consensus opinion and key messages were formulated, outlining a step-by-step approach to tackling the growing incidence of IFIs and antifungal resistance, particularly in the Indian scenario.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Wattal C, Chakrabarti A, Oberoi JK, et al. Issues in antifungal stewardship: an opportunity that should not be lost. J Antimicrob Chemother. 2017. PMID: 27999053. doi:10.1093/jac/dkw506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。